| Date Filed | Type | Description |
| 02/14/2017 |
SC 13G/A
| Cormorant Asset Management, LLC reports a 0% stake in Vitae Pharmaceuticals, Inc. |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/04/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 10/31/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 10/25/2016 |
4
| Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| LEONARD JOHN M. (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| Sable Carole (Chief Medical Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| HAYDEN DONALD J JR (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| JUNIUS DANIEL M (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Disposed/sold 20,000 options to buy
@ $11.37, valued at
$227.4k
|
|
| 10/25/2016 |
4
| Bernstein Karen (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| Fratamico Arthur (Chief Business Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
4
| SANTINI GINO (Director) has filed a Form 4 on Vitae Pharmaceuticals, Inc|
Txns:
| Disposed/sold 17,000 options to buy
@ $8, valued at
$136k
Disposed/sold 10,000 options to buy
@ $12.43, valued at
$124.3k
Disposed/sold 10,000 options to buy
@ $9.62, valued at
$96.2k
|
|
| 10/25/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/25/2016 |
4
| Applebaum Scott (General Counsel) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 10/25/2016 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 10/25/2016 |
8-K
| Quarterly results |
| 10/25/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 10/25/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/21/2016 |
4
| Gregg Richard (Chief Science Officer) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 10/17/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/11/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 10/04/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 09/26/2016 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 09/26/2016 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 09/21/2016 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 09/16/2016 |
4
| Hatfield Jeffrey S. (CEO) has filed a Form 4 on Vitae Pharmaceuticals, Inc |
| 09/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/16/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
|